Key result
Heart failure management and chemotherapy led to clinical improvement, enhanced left ventricular systolic function, and improvement of pulmonary hypertension in a patient with pulmonary tumor thrombotic microangiopathy.
Why the study?
PTTM is a rare and often fatal condition associated with poor prognosis that may be underdiagnosed when pulmonary hypertension appears attributable to heart failure.
Case Report (n=1)
Pulmonary tumor thrombotic microangiopathy (PTTM) may present with mild hemodynamic changes mimicking biventricular heart failure and can be diagnosed antemortem via pulmonary artery aspiration cytology to direct prompt life-saving chemotherapy.
BACKGROUND: Pulmonary tumor thrombotic microangiopathy (PTTM), a rare and often fatal condition characterized by tumor cell embolization within pulmonary arterioles, is frequently diagnosed using pulmonary artery aspiration cytology. PTTM is associated with poor prognosis. CASE SUMMARY: A 51-year-old woman with ovarian cancer presented with biventricular heart failure and reduced left ventricular ejection fraction. Right heart catheterization showed a mean pulmonary artery pressure of 34 mm Hg, consistent with combined pre- and postcapillary pulmonary hypertension. Despite these findings, pulmonary artery aspiration cytology confirmed the diagnosis of PTTM. The patient showed clinical improvement after heart failure management and chemotherapy. DISCUSSION: This case highlights the potential for underdiagnosing PTTM in patients with malignancies in whom pulmonary hypertension appears to be attributable to heart failure. The clinical relevance and diagnostic considerations of PTTM in such cases warrant further investigation. TAKE-HOME MESSAGE: PTTM with mild or atypical hemodynamic manifestations may be under-recognized in clinical practice.
No takes yet. Share an insight, caveat, or question.
MIHARA et al. (2025) conducted a case report in Pulmonary tumor thrombotic microangiopathy (PTTM) (n=1). Heart failure management and chemotherapy was evaluated. Heart failure management and chemotherapy led to clinical improvement, enhanced left ventricular systolic function, and improvement of pulmonary hypertension in a patient with pulmonary tumor thrombotic microangiopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: